BioGaia AB (LTS:0GTN) 3-Year FCF Growth Rate

: 17.60% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

BioGaia AB's Free Cash Flow per Share for the three months ended in Dec. 2023 was kr1.07.

During the past 12 months, BioGaia AB's average Free Cash Flow per Share Growth Rate was 25.40% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 17.60% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 17.90% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 13.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of BioGaia AB was 180.10% per year. The lowest was -33.70% per year. And the median was 22.25% per year.

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioGaia AB 3-Year FCF Growth Rate Distribution

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where BioGaia AB's 3-Year FCF Growth Rate falls into.

BioGaia AB 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

BioGaia AB (LTS:0GTN) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.

BioGaia AB 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of BioGaia AB's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

BioGaia AB (LTS:0GTN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (LTS:0GTN) » Definitions » 3-Year FCF Growth Rate

Comparable Companies

Traded in Other Exchanges

BIOGY:USA BGLAF:USA BIOG B:Sweden BGLA:Germany

Address

Kungsbroplan 3A, Stockholm, SWE, SE-112 27

Website

https://www.biogaia.se

BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

BioGaia AB (LTS:0GTN) Headlines

No Headlines